Results 211 to 220 of about 266,977 (390)

Cross Talk between Angiotensin II Type 1 and Type 2 Receptors: Cellular Mechanism of Angiotensin Type 2 Receptor-Mediated Cell Growth Inhibition.

, 1999
Masatsugu Horiuchi, Meiko Hamai, Taixing Cui, Masaru Iwai, Yasuhiko Minokoshi   +4 more
openalex   +2 more sources

A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy

EMBO Journal, 2003
T. Senbonmatsu, Takako Saito, E. Landon, Otsu Watanabe, E. Price, R. Roberts, H. Imboden, Trinita Fitzgerald, F. Gaffney, T. Inagami   +9 more
semanticscholar   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System? [PDF]

Pharmaceuticals (Basel), 2021
Danigo A, Rovini A, Bessaguet F, Bouchenaki H, Bernard A, Sturtz F, Bourthoumieu S, Desmoulière A, Magy L, Demiot C.   +9 more
europepmc   +1 more source

Role of the Angiotensin II Type-2 Receptor in the Mouse Central Nervous System

, 1999
Shigeru Okuyama, Takashi Sakagawa, Tadashi Inagami   +2 more
openalex   +1 more source

Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.

Clinical science, 2016
B. Chow, T. Allen
semanticscholar   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

G-protein-coupled receptor kinase 4 causes renal angiotensin II type 2 receptor dysfunction by increasing its phosphorylation. [PDF]

Clin Sci (Lond), 2022
Zhang F, Lei L, Huang J, Wang W, Su Q, Yan H, Chen C, Zheng S, Ren H, Li Z, Jose PA, Hu Y, Si L, Zeng C, Yang J.   +14 more
europepmc   +1 more source

Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study [PDF]

, 2019
Satoshi Imaizumi, Yuhei Shiga, Masahiro Ogawa, Hideto Sako, Yoshihisa Nagata, Akira Matsunaga, Tetsuro Shirotani, Fumihiro Hoshino, Eiji Yahiro, Yuko Uehara, Natsumi Morito, Hiroyuki Tanigawa, Dai Shimono, Mikio Fukushima, Hidekazu Sugihara, Kenji Norimatsu, Takaaki Kusumoto, Keijiro Saku, Shin‐ichiro Miura, Shin-ichiro Miura   +19 more
openalex   +1 more source

Angiotensin II type 2 receptor (ATGR2) [PDF]

Science-Business eXchange, 2014
openaire   +1 more source